Grantham, Mayo, Van Otterloo & Co (GMO)
HOLX

Grantham, Mayo, Van Otterloo & Co (GMO)’s Hologic HOLX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-320,882
Closed -$24.3M – 691
2026
Q1 		$24.3M Buy
320,882
+26,770
+9% +$2.01M 0.06% 162
2025
Q4 		$21.9M Buy
+294,112
New +$21.5M 0.06% 163
2022
Q4 		– Sell
-13,400
Closed -$865K – 739
2022
Q3 		$865K Buy
13,400
+2,600
+24% +$180K 0.01% 515
2022
Q2 		$748K Buy
+10,800
New +$802K ﹤0.01% 553
2020
Q3 		– Sell
-26,180
Closed -$1.49M – 794
2020
Q2 		$1.49M Hold
26,180
– – 0.01% 464
2020
Q1 		$919K Sell
26,180
-17,778
-40% -$846K 0.01% 509
2019
Q4 		$2.29M Buy
43,958
+3,900
+10% +$194K 0.02% 374
2019
Q3 		$2.02M Buy
40,058
+33,298
+493% +$1.64M 0.01% 426
2019
Q2 		$325K Buy
+6,760
New +$313K ﹤0.01% 649

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s HOLX Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Hologic (HOLX) in Q2 2026, closing a stake of 320,882 shares — an estimated $24.3M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HOLX in Q2 2019 and held it in 9 quarters. The position peaked at $24.3M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 320,882 Hologic shares in Q2 2026, an estimated $24.3M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Hologic in Q2 2019 and held it in 9 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Hologic position peaked at $24.3M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.